PatchMD, a leading innovator in transdermal nutrient delivery, is excited to announce the launch of its new GLP-1 Support ...

Coverage of GLP-1s is not necessarily in-your-face obvious. It leads to the conversation of whether we want to pursue weight ...

Falling short of expectations, Novo Nordisk said its investigational fixed-dose combination of cagrilintide and semaglutide in people with obesity or overweight and type 2 diabetes led to a 15.7% ...

Weight loss medications such as Wegovy and Zepbound can be effective for quick results and health benefits, but older adults ...

I’ m trying to lose the 18 pounds I have gained since the pandemic. It has been hard enough that I’ m wondering about Ozempic. I’ m also hearing about people doing Ozempic microdosing.

With increasing demand and higher costs, ensuring appropriate patient access is more critical than ever and 2025 will likely ...

Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

Excess weight can trigger chronic low-grade inflammation, which has been linked to increased risk for conditions such as heart disease and dementia. GLP-1s work by suppressing appetite and making ...

A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...

Viking Therapeutics inks broad manufacturing pact with CordenPharma to support commercialization of VK2735: San Diego Wednesday, March 12, 2025, 17:00 Hrs [IST] Viking Therapeutic ...

Health care stocks returned -9.75% in the final quarter of 2024, according to the MSCI U.S. IMI Health Care 25/50 Index, ...